Get the Stockscreener App
2.37
3.66%
-0.09
After Hours:
2.41
0.04
+1.69%
Eledon Pharmaceuticals Inc stock is traded at $2.37, with a volume of 620.09K.
It is down -3.66% in the last 24 hours and down -9.89% over the past month.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
See More
Previous Close:
$2.46
Open:
$2.56
24h Volume:
620.09K
Relative Volume:
0.79
Market Cap:
$141.92M
Revenue:
-
Net Income/Loss:
$-40.33M
P/E Ratio:
-1.324
EPS:
-1.79
Net Cash Flow:
$-39.53M
1W Performance:
-11.57%
1M Performance:
-9.89%
6M Performance:
-35.07%
1Y Performance:
-8.49%
1-Day Range:
$2.315
$2.56
1-Week Range:
$2.315
$2.71
52-Week Range:
$2.315
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Name
Eledon Pharmaceuticals Inc
Sector
Industry
Phone
949-238-8090
Address
19800 MACARTHUR BLVD., IRVINE
Compare ELDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
2.37 | 147.31M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Guggenheim | Buy |
| May-13-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-23-21 | Initiated | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Stock (ELDN) Latest News
Eledon Pharmaceuticals Inc. stock prediction for this week2025 Market Overview & Daily Oversold Bounce Ideas - newser.com
Is Eledon Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Breakouts & AI Powered Market Trend Analysis - newser.com
Energy Moves: What hedge funds are buying Eledon Pharmaceuticals IncJuly 2025 Patterns & Reliable Price Action Trade Plans - خودرو بانک
What does recent volatility data suggest for Eledon Pharmaceuticals Inc.July 2025 Momentum & Low Drawdown Momentum Trade Ideas - newser.com
Bull Bear: How does Rezolute Inc. compare to its peersJuly 2025 Trends & Safe Entry Zone Identification - خودرو بانک
What candlestick patterns are forming on Eledon Pharmaceuticals Inc.2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com
Activity Recap: Can Eledon Pharmaceuticals Inc. be recession proof2025 Sector Review & Real-Time Volume Triggers - خودرو بانک
How to forecast Eledon Pharmaceuticals Inc. trends using time series2025 Bull vs Bear & Stock Timing and Entry Methods - newser.com
Siren L.L.C. Takes $2.34 Million Position in Eledon Pharmaceuticals, Inc. $ELDN - MarketBeat
Forecasting Eledon Pharmaceuticals Inc. price range with options dataWeekly Trend Recap & Community Verified Swing Trade Signals - newser.com
Is Eledon Pharmaceuticals Inc. building a consolidation base2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
ETF Watch: Can Eledon Pharmaceuticals Inc outperform under higher oil pricesWeekly Investment Recap & Daily Growth Stock Investment Tips - خودرو بانک
Top chart patterns to watch in Eledon Pharmaceuticals Inc.July 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com
Exome Asset Management LLC Has $387,000 Stock Position in Eledon Pharmaceuticals, Inc. $ELDN - MarketBeat
Automated trading signals detected on Eledon Pharmaceuticals Inc.Trade Signal Summary & Technical Pattern Based Signals - newser.com
Sentiment analysis tools applied to Eledon Pharmaceuticals Inc.July 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Is Eledon Pharmaceuticals Inc. showing signs of accumulationJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - newser.com
Does Eledon Pharmaceuticals Inc. show high probability of reboundMarket Growth Summary & Stepwise Trade Execution Plans - newser.com
Will Eledon Pharmaceuticals Inc. rebound enough to break evenPortfolio Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Real time pattern detection on Eledon Pharmaceuticals Inc. stockWeekly Profit Summary & Verified Entry Point Signals - newser.com
What technical models suggest about Eledon Pharmaceuticals Inc.’s comebackDay Trade & Real-Time Market Trend Scan - newser.com
Published on: 2025-09-13 23:04:06 - newser.com
Is a relief rally coming for Eledon Pharmaceuticals Inc. holdersJuly 2025 EndofMonth & Real-Time Volume Triggers - Newser
Published on: 2025-09-12 19:35:20 - Newser
why eledon pharmaceuticals inc. is moving todayJuly 2025 Selloffs & Short-Term High Return Strategies - Newser
Institutional scanner results for Eledon Pharmaceuticals Inc.July 2025 Opening Moves & Risk Controlled Swing Trade Alerts - Newser
Relative strength of Eledon Pharmaceuticals Inc. in sector analysisQuarterly Portfolio Summary & Growth Oriented Trading Recommendations - Newser
Eledon Pharmaceuticals Inc. stock volume spike explainedWeekly Trade Review & Smart Investment Allocation Tips - Newser
How sentiment analysis helps forecast Eledon Pharmaceuticals Inc.July 2025 Review & Weekly High Potential Stock Alerts - Newser
Is Eledon Pharmaceuticals Inc. stock bottoming out2025 EndofYear Setup & Risk Adjusted Swing Trade Ideas - Newser
Eledon Pharmaceuticals Inc Stock (ELDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):